CME Group Inc. (NASDAQ:CME) Q3 2023 Earnings Conference Call October 25, 2023 8:30 AM ET Company Participants Adam Minick - Senior Director, IR Terrence Duffy - Chairman and CEO Lynne Fitzpatrick - CFO Tim McCourt - Senior Managing Director and Global Head, Equity & FX Products Derek Sammann - Senior Managing Director and Global Head, Commodities, Options & International Markets Julie Winkler - Chief Commercial Officer Suzanne Sprague - Senior Managing Director and Global Head Of Clearing and Post-Trade Ser ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________________ FORM 10-Q _________________________________________________________ (Mark One) For the transition period from to Commission file number 001-31553 Table of Contents ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 - OR - ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHAN ...

CME Group Inc. (NASDAQ:CME) Q2 2023 Earnings Conference Call July 26, 2023 8:30 AM ET Company Participants Adam Minick - Senior Director, IR Terrence Duffy - Chairman & CEO Lynne Fitzpatrick - CFO Tim McCourt - Senior Managing Director and Global Head, Equity & FX Products Derek Sammann - Senior Managing Director and Global Head, Commodities, Options & International Markets Julie Winkler - Chief Commercial Officer Sunil Cutinho - Chief Information Officer Conference Call Participants Benjamin Budish - Barcl ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________________ FORM 10-Q _________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 - OR - ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file n ...

CME Group Inc. (NASDAQ:CME) Q1 2023 Earnings Conference Call April 26, 2023 8:30 AM ET Company Participants Adam Minick - Senior Director, Investor Relations Terry Duffy - Chairman & Chief Executive Officer Lynne Fitzpatrick - Chief Financial Officer Sean Tully - Senior Managing Director & Global Head, Rates & OTC Products John Pietrowicz - Special Advisor Julie Winkler - Chief Commercial Officer Sunil Cutinho - Chief Information Officer Tim McCourt - Senior Managing Director and Global Head, Equity & FX Pr ...

Financial Performance - Total revenues for 2022 were $5,019.4 million, representing a 7% increase from $4,689.7 million in 2021[150] - Total expenses decreased to $2,003.5 million in 2022 from $2,044.5 million in 2021, a reduction of 2%[150] - Operating margin improved to 60.1% in 2022, up from 56.4% in 2021[150] - Net income attributable to CME Group increased by 2% to $2,691.0 million in 2022 compared to $2,636.4 million in 2021[150] - Diluted earnings per share rose by 2% to $7.40 in 2022 from $7.29 in 2021[150] - Cash flows from operating activities increased by 27% to $3,056.0 million in 2022 from $2,402.4 million in 2021[150] Revenue Breakdown - Clearing and transaction fees revenue increased by 10% to $4,142.7 million in 2022 from $3,765.1 million in 2021[171] - Market data and information services revenue grew by 6% to $610.9 million in 2022 from $576.9 million in 2021[171] - Other revenue decreased by 24% to $265.8 million in 2022 from $347.7 million in 2021[171] Business Strategy - CME Group's business strategy includes expanding electronic trading platforms and optimizing capital management services[156] - The company aims to maximize futures and options growth globally and diversify its business and revenues through partnerships, including with Google Cloud[158] - The strategy includes delivering unparalleled customer efficiencies and operational excellence across a wide range of products and asset classes[158] Regulatory and Competitive Environment - The competitive environment is expected to intensify due to ongoing regulatory reforms in the financial services industry[157] - The regulatory environment may require significant financial and operational resources for compliance, potentially affecting profitability[157] Risk Management - The company is exposed to significant credit risk from third parties, including clearing firms, and has established performance bond requirements to mitigate this risk[326] - The company continues to adapt its trading technology and clearing services to meet evolving market needs[157] Capital and Liquidity - The company maintains a $7.0 billion multi-currency line of credit, with the option to increase it to $10.0 billion, to provide temporary liquidity in case of a clearing firm default[327] - As of December 31, 2022, aggregate performance bond deposits for clearing firms totaled $231.5 billion, which includes cash and non-cash deposits[327] - The company has a $2.3 billion multi-currency revolving senior credit facility, which can be increased to $3.3 billion with lender consent[344] - The company has a 364-day multi-currency revolving secured credit facility with a borrowing capacity of up to $7.0 billion, with no outstanding borrowings as of December 31, 2022[346] - The company maintains fixed-rate borrowings of $3.4 billion as of December 31, 2022, with no variable-rate borrowings[349] - The company has excess borrowing capacity of approximately $2.3 billion under its multi-currency revolving senior credit facility as of December 31, 2022[346] - The company is in compliance with all covenant requirements of its debt facilities as of December 31, 2022[346] - The company expects to maintain an investment grade rating based on its cash flow generation and ability to manage debt levels[346] - The company has a $350 million line of credit to meet obligations under its agreement with Singapore Exchange Limited[346] Dividend and Capital Expenditures - A regular quarterly dividend of $1.10 per share was declared, totaling approximately $400.0 million for the first quarter of 2023[344] - The company plans to incur approximately $100.0 million in capital expenditures in 2023 to support growth and improve system capacity[344] Currency and Foreign Transactions - The company recognized a net gain of $13.2 million in 2022 due to currency exchange rate fluctuations, compared to a net gain of $0.4 million in 2021[339] - Aggregate foreign currency transaction gains for 2022 were $13.2 million, compared to $0.4 million in 2021 and a loss of $(9.3) million in 2020[356] Pension Plan - The company aims to have its pension plan 100% funded at each year-end, with no additional contributions expected for 2023 based on actuarial projections[347]

CME Group Inc. (NASDAQ:CME) Q4 2022 Earnings Conference Call February 8, 2023 8:30 AM ET Company Participants Adam Minick - Investor Relations Terrence Duffy - Chairman and Chief Executive Officer Sean Tully - Senior Managing Director and Global Head, Rates & OTC Products Tim McCourt - Senior Managing Director and Global Head, Equity & FX Products Derek Sammann - Senior Managing Director and Global Head, Commodities, Options & International Markets Julie Winkler - Chief Commercial Officer John Pietrowicz - ...

• SOFR and Treasury options were added into CME Group's Portfolio Margining with OTC Swaps on December 12, 2022. Client average daily savings were $8.4 billion in 4Q22 • December SOFR futures RPC is closely approaching legacy Eurodollar futures RPC With significant rally of the U.S. dollar throughout most of 2022, and varying pace of global central bank policies causing interest rate differentials, the global foreign exchange market is in a highervolatility environment and CME Group FX ADV has come alive in ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________________ FORM 10-Q _________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 - OR - ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission fi ...

CME Group, Inc. (NASDAQ:CME) Q3 2022 Earnings Conference Call October 26, 2022 8:30 AM ET Company Participants John Peschier - MD, IR Terrence Duffy - Chairman & CEO Sean Tully - Senior MD and Global Head, Rates & OTC Products Tim McCourt - Senior MD & Global Head, Equity & FX Products Derek Sammann - Senior MD and Global Head, Commodities, Options & International Markets John Pietrowicz - CFO Julie Winkler - Senior MD & Chief Commercial Officer Sunil Cutinho - Chief Information Officer Conference Call Part ...